WallStreetZenWallStreetZen

NASDAQ: PROF
Profound Medical Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PROF

Based on 1 analyst offering 12 month price targets for Profound Medical Corp.
Min Forecast
$12.00+56.05%
Avg Forecast
$12.00+56.05%
Max Forecast
$12.00+56.05%

Should I buy or sell PROF stock?

Based on 1 analyst offering ratings for Profound Medical Corp.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PROF stock forecasts and price targets.

PROF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-07-16Find Out Why

1 of 1

Forecast return on equity

Is PROF forecast to generate an efficient return?
Company
163.91%
Industry
25.39%
Market
48.93%
PROF's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PROF forecast to generate an efficient return on assets?
Company
128.55%
Industry
13.53%
PROF is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PROF earnings per share forecast

What is PROF's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$1.13
Avg 2 year Forecast
-$0.85
Avg 3 year Forecast
-$0.41

PROF revenue forecast

What is PROF's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$11.3M+97.03%
Avg 2 year Forecast
$30.0M+421.57%
Avg 3 year Forecast
$49.2M+755.95%
PROF's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PROF revenue growth forecast

How is PROF forecast to perform vs Medical Devices companies and vs the US market?
Company
105.42%
Industry
7.25%
Market
9.84%
PROF's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PROF's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PROF vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PROF$7.69$12.00+56.05%Strong Buy
SENS$0.35$2.00+464.97%Buy
NPCE$6.61$13.67+106.76%Strong Buy
ARAY$1.83N/AN/A
ELMD$22.67N/AN/A
View Top Medical Device Stocks

Profound Medical Stock Forecast FAQ

Is Profound Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PROF) stock is to Strong Buy PROF stock.

Out of 1 analyst, 1 (100%) are recommending PROF as a Strong Buy, 0 (0%) are recommending PROF as a Buy, 0 (0%) are recommending PROF as a Hold, 0 (0%) are recommending PROF as a Sell, and 0 (0%) are recommending PROF as a Strong Sell.

If you're new to stock investing, here's how to buy Profound Medical stock.

What is PROF's earnings growth forecast for 2024-2026?

(NASDAQ: PROF) Profound Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 27.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.87%.

Profound Medical's earnings in 2024 is -$18,071,942.On average, 4 Wall Street analysts forecast PROF's earnings for 2024 to be -$27,542,064, with the lowest PROF earnings forecast at -$30,112,657, and the highest PROF earnings forecast at -$23,502,562. On average, 3 Wall Street analysts forecast PROF's earnings for 2025 to be -$20,809,560, with the lowest PROF earnings forecast at -$21,544,015, and the highest PROF earnings forecast at -$20,075,105.

In 2026, PROF is forecast to generate -$10,118,342 in earnings, with the lowest earnings forecast at -$22,768,107 and the highest earnings forecast at $5,141,185.

What is PROF's revenue growth forecast for 2024-2026?

(NASDAQ: PROF) Profound Medical's forecast annual revenue growth rate of 105.42% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.25%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.84%.

Profound Medical's revenue in 2024 is $5,669,064.On average, 3 Wall Street analysts forecast PROF's revenue for 2024 to be $277,452,636, with the lowest PROF revenue forecast at $271,748,369, and the highest PROF revenue forecast at $281,541,103. On average, 3 Wall Street analysts forecast PROF's revenue for 2025 to be $734,455,050, with the lowest PROF revenue forecast at $421,087,562, and the highest PROF revenue forecast at $1,160,438,979.

In 2026, PROF is forecast to generate $1,205,314,183 in revenue, with the lowest revenue forecast at $656,113,178 and the highest revenue forecast at $2,039,336,856.

What is PROF's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PROF) forecast ROA is 128.55%, which is higher than the forecast US Medical Devices industry average of 13.53%.

What is PROF's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PROF price target, the average PROF price target is $12.00, with the highest PROF stock price forecast at $12.00 and the lowest PROF stock price forecast at $12.00.

The Wall Street analyst predicted that Profound Medical's share price could reach $12.00 by Jul 16, 2025. The average Profound Medical stock price prediction forecasts a potential upside of 56.05% from the current PROF share price of $7.69.

What is PROF's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: PROF) Profound Medical's current Earnings Per Share (EPS) is -$0.88. On average, analysts forecast that PROF's EPS will be -$1.13 for 2024, with the lowest EPS forecast at -$1.23, and the highest EPS forecast at -$0.96. On average, analysts forecast that PROF's EPS will be -$0.85 for 2025, with the lowest EPS forecast at -$0.88, and the highest EPS forecast at -$0.82. In 2026, PROF's EPS is forecast to hit -$0.41 (min: -$0.93, max: $0.21).

What is PROF's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PROF) forecast ROE is 163.91%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.